Literature DB >> 25231116

The impact of accelerometer use in exercise-associated hypoglycemia prevention in type 1 diabetes.

Matthew Stenerson1, Fraser Cameron2, Shelby R Payne1, Sydney L Payne1, Trang T Ly1, Darrell M Wilson1, Bruce A Buckingham3.   

Abstract

Exercise-associated hypoglycemia is a common adverse event in people with type 1 diabetes. Previous in silico testing by our group demonstrated superior exercise-associated hypoglycemia mitigation when a predictive low glucose suspend (PLGS) algorithm was augmented to incorporate activity data. The current study investigates the effectiveness of an accelerometer-augmented PLGS algorithm in an outpatient exercise protocol. Subjects with type 1 diabetes on insulin pump therapy participated in two structured soccer sessions, one utilizing the algorithm and the other using the subject's regular basal insulin rate. Each subject wore their own insulin pump and a Dexcom G4™ Platinum continuous glucose monitor (CGM); subjects on-algorithm also wore a Zephyr BioHarness™ 3 accelerometer. The algorithm utilized a Kalman filter with a 30-minute prediction horizon. Activity and CGM readings were manually entered into a spreadsheet and at five-minute intervals, the algorithm indicated whether the basal insulin infusion should be on or suspended; any changes were then implemented by study staff. The rate of hypoglycemia during and after exercise (until the following morning) was compared between groups. Eighteen subjects (mean age 13.4 ± 3.7 years) participated in two separate sessions 7-22 days apart. The difference in meter blood glucose levels between groups at each rest period did not achieve statistical significance at any time point. Hypoglycemia during the session was recorded in three on-algorithm subjects, compared to six off-algorithm subjects. In the postexercise monitoring period, hypoglycemia occurred in two subjects who were on-algorithm during the session and four subjects who were off-algorithm. The accelerometer-augmented algorithm failed to prevent exercise-associated hypoglycemia compared to subjects on their usual basal rates. A larger sample size may have achieved statistical significance. Further research involving an automated system, a larger sample size, and an algorithm design that favors longer periods of pump suspension is necessary.
© 2014 Diabetes Technology Society.

Entities:  

Keywords:  accelerometer; exercise; hypoglycemia; predictive low glucose suspend; pump suspension; type 1 diabetes

Mesh:

Substances:

Year:  2014        PMID: 25231116      PMCID: PMC4495548          DOI: 10.1177/1932296814551045

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  13 in total

1.  Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study.

Authors:  Satish Garg; Ronald L Brazg; Timothy S Bailey; Bruce A Buckingham; Robert H Slover; David C Klonoff; John Shin; John B Welsh; Francine R Kaufman
Journal:  Diabetes Technol Ther       Date:  2012-02-08       Impact factor: 6.118

2.  Poor adherence to integral daily tasks limits the efficacy of CSII in youth.

Authors:  M A O'Connell; S Donath; F J Cameron
Journal:  Pediatr Diabetes       Date:  2011-04-06       Impact factor: 4.866

3.  Adherence to physical activity in young people with type 1 diabetes.

Authors:  Anna Lucia Bernardini; Maurizio Vanelli; Giovanni Chiari; Brunella Iovane; Chiara Gelmetti; Rosa Vitale; Maria Katrin Errico
Journal:  Acta Biomed       Date:  2004-12

4.  Prevention of hypoglycemia during exercise in children with type 1 diabetes by suspending basal insulin.

Authors:  Eva Tsalikian; Craig Kollman; William B Tamborlane; Roy W Beck; Rosanna Fiallo-Scharer; Larry Fox; Kathleen F Janz; Katrina J Ruedy; Darrell Wilson; Dongyuan Xing; Stuart A Weinzimer
Journal:  Diabetes Care       Date:  2006-10       Impact factor: 19.112

5.  Endurance athletes and type 1 diabetes.

Authors:  Mercy Devadoss; Laura Kennedy; Nancie Herbold
Journal:  Diabetes Educ       Date:  2011-02-15       Impact factor: 2.140

6.  Inpatient studies of a Kalman-filter-based predictive pump shutoff algorithm.

Authors:  Fraser Cameron; Darrell M Wilson; Bruce A Buckingham; Hasmik Arzumanyan; Paula Clinton; H Peter Chase; John Lum; David M Maahs; Peter M Calhoun; B Wayne Bequette
Journal:  J Diabetes Sci Technol       Date:  2012-09-01

Review 7.  The artificial pancreas: current status and future prospects in the management of diabetes.

Authors:  Thomas Peyser; Eyal Dassau; Marc Breton; Jay S Skyler
Journal:  Ann N Y Acad Sci       Date:  2014-04       Impact factor: 5.691

8.  The Impact of Accelerometer and Heart Rate Data on Hypoglycemia Mitigation in Type 1 Diabetes.

Authors:  Matthew Stenerson; Fraser Cameron; Darrell M Wilson; Breanne Harris; Shelby Payne; B Wayne Bequette; Bruce A Buckingham
Journal:  J Diabetes Sci Technol       Date:  2014-01-01

9.  High incidence of hypoglycemic episodes with neurologic manifestations in children with insulin dependent diabetes mellitus.

Authors:  N Shehadeh; J Kassem; I Tchaban; S Ravid; E Shahar; T Naveh; A Etzioni
Journal:  J Pediatr Endocrinol Metab       Date:  1998-03       Impact factor: 1.634

10.  Adding heart rate signal to a control-to-range artificial pancreas system improves the protection against hypoglycemia during exercise in type 1 diabetes.

Authors:  Marc D Breton; Sue A Brown; Colleen Hughes Karvetski; Laura Kollar; Katarina A Topchyan; Stacey M Anderson; Boris P Kovatchev
Journal:  Diabetes Technol Ther       Date:  2014-04-04       Impact factor: 6.118

View more
  16 in total

1.  Incorporating an Exercise Detection, Grading, and Hormone Dosing Algorithm Into the Artificial Pancreas Using Accelerometry and Heart Rate.

Authors:  Peter G Jacobs; Navid Resalat; Joseph El Youssef; Ravi Reddy; Deborah Branigan; Nicholas Preiser; John Condon; Jessica Castle
Journal:  J Diabetes Sci Technol       Date:  2015-10-05

Review 2.  Physical Activity Capture Technology With Potential for Incorporation Into Closed-Loop Control for Type 1 Diabetes.

Authors:  Vikash Dadlani; James A Levine; Shelly K McCrady-Spitzer; Eyal Dassau; Yogish C Kudva
Journal:  J Diabetes Sci Technol       Date:  2015-10-18

Review 3.  Moving Toward a Unified Platform for Insulin Delivery and Sensing of Inputs Relevant to an Artificial Pancreas.

Authors:  Anneke Graf; Sybil A McAuley; Catriona Sims; Johanna Ulloa; Alicia J Jenkins; Gayane Voskanyan; David N O'Neal
Journal:  J Diabetes Sci Technol       Date:  2016-12-13

Review 4.  Physical activity and type 1 diabetes: time for a rewire?

Authors:  Sheri R Colberg; Remmert Laan; Eyal Dassau; David Kerr
Journal:  J Diabetes Sci Technol       Date:  2015-01-06

5.  Identification of Main Factors Explaining Glucose Dynamics During and Immediately After Moderate Exercise in Patients With Type 1 Diabetes.

Authors:  Najib Ben Brahim; Jerome Place; Eric Renard; Marc D Breton
Journal:  J Diabetes Sci Technol       Date:  2015-10-18

Review 6.  Multivariable Adaptive Artificial Pancreas System in Type 1 Diabetes.

Authors:  Ali Cinar
Journal:  Curr Diab Rep       Date:  2017-08-15       Impact factor: 4.810

7.  Prediction of Hypoglycemia During Aerobic Exercise in Adults With Type 1 Diabetes.

Authors:  Ravi Reddy; Navid Resalat; Leah M Wilson; Jessica R Castle; Joseph El Youssef; Peter G Jacobs
Journal:  J Diabetes Sci Technol       Date:  2019-01-17

8.  Improving Glucose Prediction Accuracy in Physically Active Adolescents With Type 1 Diabetes.

Authors:  Nicole Hobbs; Iman Hajizadeh; Mudassir Rashid; Kamuran Turksoy; Marc Breton; Ali Cinar
Journal:  J Diabetes Sci Technol       Date:  2019-01-18

9.  The Promise and Perils of Wearable Physiological Sensors for Diabetes Management.

Authors:  Frank L Schwartz; Cynthia R Marling; Razvan C Bunescu
Journal:  J Diabetes Sci Technol       Date:  2018-03-15

10.  Randomized trial of a dual-hormone artificial pancreas with dosing adjustment during exercise compared with no adjustment and sensor-augmented pump therapy.

Authors:  P G Jacobs; J El Youssef; R Reddy; N Resalat; D Branigan; J Condon; N Preiser; K Ramsey; M Jones; C Edwards; K Kuehl; J Leitschuh; U Rajhbeharrysingh; J R Castle
Journal:  Diabetes Obes Metab       Date:  2016-08-15       Impact factor: 6.577

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.